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Introduction
The nuclear envelope (NE) creates a compartment within the
interphase cell in which DNA replication, transcription and
RNA processing can be regulated independently of translation.
Components of the NE include the inner nuclear membrane
(INM) and outer nuclear membrane (ONM), nuclear pore
complexes (NPCs) and the nuclear lamina. The lamina is a
fibrous nucleoskeletal structure associated with the INM
through interactions with integral membrane proteins. The
lamina also interlinks adjacent NPCs (reviewed by Vaughan et
al., 2000).
Nuclear lamins are the major components of the lamina.
Analysis of cDNA sequences that encode nuclear lamins has
confirmed that they are closely related to the cytoplasmic
intermediate filament (IF) protein family (Fisher et al., 1986).
As such, the lamins have been classified as type V IFs, and
share a common primary sequence consisting of globular N-
and C-terminal domains and a central a -helical rod domain.
The rod domain can be divided into four a -helical segments,
coil 1a, coil 1b, coil 2a, and coil 2b, which are separated
by non- a -helical linker sequences (Fig. 1). Unlike the rod
domains of cytoplasmic IFs, the rod domains of lamins contain
an additional six heptad repeats in coil 1b. Lamins are classified
as either A-type or B-type, depending on their primary
sequence, behaviour at mitosis and tissue-specific expression
patterns. B-type lamins are constitutively expressed in all
embryonic and somatic tissues studied to date. In vertebrates,
lamins B1 and B2 are closely related in sequence but are the
products of separate genes. In amphibian and avian species,
these lamins are expressed from the blastula stage of
development onwards (Stick and Hausen, 1985; Lehner et al.,
1987). B-type lamins, which are specialised for meiosis and
early embryogenesis are expressed in at least some organisms.
A sperm-specific B-type lamin (lamin LIV) has been identified
in Xenopus (Benavente et al., 1985). In addition, lamin B3 is
expressed in Xenopus oocytes and early embryos (Stick and
Hausen, 1985). Lamins LIV and B3 are both the products of
individual genes. A spermatocyte-specific lamin also termed
lamin B3, which is a splicing variant of lamin B2, has also been
identified in mouse (Furukawa and Hotta, 1993), but note that
mouse lamin B3 and Xenopus lamin B3 are not homologous.
The A-type lamins, lamin A and lamin C, are also alternatively
spliced products of the same gene, as is the more recently
described lamin AD 10, but are expressed exclusively in
differentiated cells and tissues (Stick and Hausen, 1985;
Lehner et al., 1987; Rober et al., 1989). Developmental control
of A-type lamin expression has led to the suggestion that they
stabilise differential gene expression (Nigg, 1989). 
Lamin modificiations
The C-terminal tail domains of lamins contain several motifs
that are essential for their correct distribution. A nuclear-
localisation signal (NLS) is located close to the a -helical rod
domain, although the exact position within the tail domain does
vary between different lamins. The NLS is required for nuclear
import and is homologous to the prototype NLS of the SV40
large T antigen. Furthermore, the C-terminal ends of all the B-
type lamins and lamin A contain a sequence motif CaaX (C,
cysteine; a, any aliphatic amino acid; X, any amino acid). The
motif is modified by farnesylation of the C-terminal cysteine
residue, followed by cleavage of the three N-terminal residues
and carboxy-methylation of the cysteine. The added
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The nuclear lamina is a filamentous structure composed of
lamins that supports the inner nuclear membrane. Several
integral membrane proteins including emerin, LBR, LAP1
and LAP2 bind to nuclear lamins in vitro and can influence
lamin function and dynamics in vivo. Results from various
studies suggest that lamins function in DNA replication and
nuclear envelope assembly and determine the size and
shape of the nuclear envelope. In addition, lamins also bind
chromatin and certain DNA sequences, and might influence
chromosome position. Recent evidence has revealed that
mutations in A-type lamins give rise to a range of rare, but
dominant, genetic disorders, including Emery-Dreifuss
muscular dystrophy, dilated cardiomyopathy with
conduction-system disease and Dunnigan-type familial
partial lipodystrophy. An examination of how lamins A/C,
emerin and other integral membrane proteins interact at
the INM provides the basis for a novel model for how
mutations that promote disease phenotypes are likely to
influence these interactions and therefore cause cellular
pathology through a combination of weakness of the lamina
or altered gene expression.
Key words: Nuclear lamina, Lamin, LAP, Emery-Dreyfuss muscular
dystrophy, Congenital cardiomyopathy, Partial lipodystrophy
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hydrophobic prenyl moiety appears to target (and anchor)
lamins to the nuclear membrane (Vorburger et al., 1989). B-
type lamins remain farnesylated throughout their lifetime,
whereas lamin A is processed further. The C-terminal 15
residues of lamin A (including the prenyl tail) are removed by
proteolytic cleavage to yield mature lamin A (Sasseville and
Raymond, 1995) (Fig. 1). The different processing pathways
for B-type lamins and lamin A probably explain their different
behaviours at mitosis (see below).
Along with the rest of the NE, the lamina is disassembled
and reassembled during mitosis. Both in vivo and in vitro
assays suggest that the mitotic CDC2 kinase, protein kinase
C (PKC), and cyclic-AMP-dependent kinase (PKA)
phosphorylation sites are important in lamin assembly as
well as disassembly (Moir et al., 1995). In addition, protein
phosphatases have been implicated in lamina assembly
(Murphy et al., 1995). Phosphorylation/dephosphorylation of
lamins during interphase can modulate lamina filament
assembly in a number of ways. Phosphorylation at sites
adjacent to the NLS by PKC can influence the rate at which
lamins enter the nucleus, thus limiting the availability of
filament subunits (Hennekes et al., 1993). Phosphorylation by
PKA facilitates the incorporation of new lamin subunits into
the assembled lamina structure as the nucleus grows (Peter et
al., 1990). Finally, the rate of dephosphorylation by PP1a at
CDK1 sites can influence the initial rate of lamin filament
assembly at telophase (Thompson et al., 1997). All these
regulatory events probably ensure the assembly of 10–13-nm
filaments in vivo. Following disassembly, lamins A and C are
‘soluble’ during mitosis (they are probably present as dimers
and/or tetramers), whereas the
rest of the time, B-type lamins
generally remain attached to
nuclear membrane vesicles
(Gerace and Blobel, 1980). 
Lamin associations and
binding proteins
Several INM proteins have
been shown to interact directly
with nuclear lamins in vitro and
to remain closely associated
with the nuclear lamina after
extraction of nuclei with non-
ionic detergents, nucleases
and/or high-salt buffers
(Foisner and Gerace, 1993;
Stuurman et al., 1998; Fairley
et al., 1999). The lamin B
receptor (LBR), also termed
p58, was the first of these to be
identified (see Moir et al.,
1995) and is probably the best
characterised. LBR has an
N-terminal nucleoplasmic
domain and a C-terminal
region that includes eight
predicted transmembrane
domains. The nucleoplasmic
domain interacts with B-type
lamins, a human chromatin-
associated protein (HP1) and chromatin in vitro (see Stuurman
et al., 1998). This domain also contains phosphorylation sites
for PKA, CDC2 and an arginine-serine (RS)-specific kinase
(Simos et al., 1996; Nikolakaki et al., 1996; Nikolakaki et al.,
1997). The RS kinase co-isolates with LBR and other NE
components as a multimeric complex from avian erythrocyte
NEs. The complex includes nuclear lamins, p34/32 (which
might be involved in RNA splicing) and the integral membrane
protein p18 (which binds to B-type lamins in vitro: Simos et
al., 1996). Using chicken hepatoma cells, Meier and Georgatos
have also shown that LBR and B-type lamins co-segregate in
the same mitotic vesicles (Meier and Georgatos, 1994).
Similarly, in Xenopus eggs, xLBR and lamin B3 also co-
segregate in the same vesicle population (Drummond et al.,
1999).
Lamin-associated proteins (LAPs), LAP1A, LAP1B,
LAP1C, and LAP2, were initially identified in rat liver NE
fractions (Foisner and Gerace, 1993). All LAPs contain
predicted long N-terminal nucleoplasmic domains, a single
transmembrane segment and a short C-terminal lumenal tail.
Three of these proteins, LAP1A, LAP1B and LAP1C, are
closely related and are probably alternatively spliced products
of the same gene. LAP2 proteins are also expressed as a variety
of isoforms (a , b , g , d , e and x ), all being alternatively spliced
products of a single gene. Of these isoforms all except LAP2 a
possess a conserved membrane-spanning domain and are
therefore type II integral membrane proteins. LAP2a possesses
an extended and unique C-terminal domain and forms part of
the nuclear matrix (Foisner and Gerace, 1993; Dechat et al.,
1998; Harris et al., 1995). Analysis of extracted NE fractions,
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Fig. 1. Schematic representation of somatic cell lamins. Coloured rectangles represent a -helical coiled-
coil domains; B-type lamins are shaded in green, and A-type lamins are shaded in red. The blue shaded
area within coil 1b shows the position of the heptad repeat extension, which is unique to the lamins.
NLS=nuclear localisation signal sequence; CaaX is the site for carboxy methylation, prenylation and
proteolytic cleavage. Coloured regions in the C-terminal tail domains show the major sites of amino acid
residue variation among the lamin subtypes. The stylised cytoplasmic IF illustrates differences in
organisation for comparison. The central rod domain is shorter (owing to the absence of the heptad
repeat extension in coil 1b). The head domain is generally longer and varies between IF types. The tail
domain lacks an NLS and CaaX.
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combined with in vitro binding studies, has indicated that
LAP1A and LAP1B (but not LAP1C) interact with lamin A,
lamin C and lamin B1, whereas LAP2 b associates specifically
with lamin B1 and chromatin. The affinities of the integral
membrane LAP2 isoforms for lamins have not as yet been
determined, although the affinity of LAP2 a for lamins is
described below. The affinity of LAP2 b for lamin B1 and
chromatin is reduced in the presence of CDC2 activity (Foisner
and Gerace, 1993). 
Although LAP1C has not been shown to interact with
nuclear lamins in vitro, its localisation within the nuclear
envelope appears to be lamin dependent. Powell and Burke
reported that LAP1C translocates between the INM and ONM
in undifferentiated P19 cells (Powell and Burke, 1990). When
P19 cells are transfected with lamin A, LAP1C becomes
immobilised at the INM. In contrast to these findings, other
investigations suggest that LAP1C is anchored at the NE as
part of a multimeric complex that includes LAP1A, B-type
lamins (but not A-type lamins) and a protein kinase activity
distinct from that associated with LBR (Maison et al., 1997).
LAP2b has been characterised more fully and does not appear
to have a role in the initial phase of NE assembly
(Pyrpasopoulou et al., 1996). Yang et al. have mapped distinct
lamin-binding and chromatin-binding domains to the N-
terminal nucleoplasmic domain of LAP2b (Yang et al., 1997a).
Moreover, LAP2b also binds to specifically to lamin B1 within
coil 1b. Yang and co-workers (1997) were able to inhibit
lamina assembly, NE growth and entry into S phase by
microinjecting peptides corresponding to the lamin-binding
domain of LAP2 b (but not the chromatin-binding domain)
into mitotic and early G1 phase cells. Similarly, Gant and
co-workers demonstrated that GST-LAP2 fusion peptides
containing regions of the LAP2 N-terminal nucleoplasmic
domain also inhibited some aspects of NE assembly and,
in particular, lamina assembly in cell-free extracts of
Xenopus eggs (Gant et al., 1999). Thus, there is strong
evidence to suggest that LAP2 b plays an important role in
lamina assembly.
Recently, Dechat et al. have identified a splice variant of
LAP2, LAP 2 a (Dechat et al., 1998). LAP2 a does not
possess a C-terminal transmembrane-spanning domain but
instead has a long N-terminal extension that includes an
NLS. Thus, LAP2a is distributed in the nucleoplasm
(rather than in the NE), where it associates with chromatin
(Vlcek et al., 1999). Recently, Dechat et al. have also shown
that LAP2 a associates specifically with A-type lamins in
vivo and in vitro and that its nuclear distribution is
influenced by lamin A (Dechat et al., 2000).
The INM protein emerin is related to both the LAPs in
that it is also a type II integral membrane protein and its N-
terminal nucleoplasmic domain possesses the LEM (LAP,
Emerin, MAN) motif common to several INM proteins.
Emerin binds to A-type and B-type lamins in nuclear
extracts and in vitro. In addition, the distribution of emerin
at the INM is dependent upon the presence of A-type
lamins and specifically lamin A (Fairley et al., 1999;
Sullivan et al., 1999; Vaughan et al., 2000). Thus it seems
likely that emerin specifically associates with lamin A or
lamin C in vivo.
Lamina filament assembly and organization
Most cytoplasmic IF proteins can self-assemble into 10–13-nm
filaments in vitro. In contrast lamin polypeptides form
paracrystals in vitro (Quinlan et al., 1995). Paracrystals are
assemblies of intermediate filaments that overextend laterally
to give rise to thickened structures (>13 nm diameter) with a
repeated (every 23 nm) striated appearance through their
length. This makes an investigation of lamin filament assembly
intrinsically more difficult. However, several methods have
been used to investigate the mechanism(s) of lamin filament
assembly, including the EM analysis of the self-assembly
properties of purified recombinant wild-type and mutant
lamins, and chemical cross-linking within native laminae
(reviewed within Stuurman et al., 1998). These studies suggest
that the initial events in lamin assembly in vitro involve lateral
interaction between two lamin chains to form parallel
unstaggered homodimers, through coiled-coil association of
the a -helical rod domains. 
The lamin dimers can then associate longitudinally to form
head-to-tail polymers. In vitro binding studies of mutant
Drosophila lamins have shown that amino acid residues at the
N-terminal end of coil 1a and at the C-terminal end of coil 2
are essential for head-to-tail polymerisation of lamin dimers.
Lamin filaments of 10 nm diameter can form in vivo by lateral
anti-parallel association of head-to-tail polymers. This type of
association certainly does occur in vitro but results in
formation of large paracrystals (Moir et al., 1991; Heitlinger et
al., 1991). Therefore, do lamina filaments only assemble at the
NE? Early studies revealed that post-translational modification
isoprene receptorLAP2 b
nuclear membrane
(LBR?)
head-to-tail assembly
prenylated lamin B dimers associating
as N-N half staggered anti-parallel 
tetramers
constrained assembly of a protofilament
Fig. 2. Cartoon showing the constrained polymerisation of B-type
lamin filaments at the INM. Tethering of B-type lamins to the INM
in this model is through association with LAP2 b through coil 1b and
through an isoprene receptor (possibly LBR) (after the work of Gant
et al., 1999 and Mical and Montiero, 1998). Lamin B dimers form N-
N half-staggered anti-parallel associations to make tetramers and
head-to-tail associations to form higher-order structures such as
proto-filaments.
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of the C-terminal CaaX motif is essential for targeting of
lamins to the NE (Holtz et al., 1989; Krohne et al., 1989; Kitten
and Nigg, 1991; Hennekes and Nigg, 1994). Indeed, mutant
lamins that lack this motif preferentially assemble into
crystalline structures in the nucleoplasm (Mical and Montiero,
1998; Izumi et al., 2000). Moreover, although the CaaX motif
is necessary for NE localisation of the lamins, it is not in itself
sufficient to anchor lamins to nuclear membranes; this finding
has given rise to the notion that an isoprenyl receptor resides
at the NE (Firmbach-Kraft and Stick, 1995). Since a lamin B1
mutant lacking the CaaX motif segregates independently of
LBR at mitosis (Mical and Montiero, 1998), it is possible that
LBR is the isoprene receptor. In more recent studies, LAP2 b ,
which binds specifically to a region within coil 1b of B-type
lamins, has been shown to play an essential role in the initial
assembly of the lamina (Yang et al., 1997a; Yang et al., 1997b;
Gant et al., 1999). 
Thus, we can develop a model for how lamina filaments
polymerise as a 2D array at the INM (Fig. 2). Lamin dimers
are localised at the INM through interactions with an isoprene
receptor and LAP2b . Because of the nature of these
interactions (i.e. the first occurs through the tail of the lamin,
wheras the second involves the N terminus of the rod domain)
and because lamin dimers are intrinsically stiff molecules,
these initial associations force the lamin dimer to lie parallel
to the INM. Since in vitro evidence suggests that the preferred
mode of assembly is head-to-tail, and because lamin dimers are
forced into parallel alignment with the INM, presumably
10–13-nm filaments assemble as a flattened array subjacent to
the INM. Take away this anchorage to the INM, and the
proteins form paracrystals in the nucleoplasm. We wish to
make two important points here. First, the basic lamina
structure must be based around B-type lamins (see below).
Second, we propose a constrained mechanism for filament
assembly that is directly analogous to the constraints that
influence the formation of cytoplasmic IF networks. In the
nucleus, the constraining elements are probably LAP2 b and the
putative isoprene receptor (possibly LBR), whereas in the
cytoplasm the constraining elements are small heat-shock
proteins and molecular chaperones such as ab crystallins
(Quinlan and Van Den Ijssel, 1999).
An important factor is of course missing: why does the
lamina form an orthogonol meshwork? The evidence for
such a meshwork is from spread nuclear envelopes manually
dissected from amphibian oocyte germinal vesicles (GVs; see
Fig. 3). Note that ultrastructural examinations of this type have
so far only been possible in oocyte GVs, and the precise
arrangement of lamina filaments might differ in somatic cell
nuclei. Two structural elements are self evident in the
micrograph: first, the filaments extend between NPCs and
physically associate with the nucleoplasmic ring of the NPCs;
second, where filaments cross, there is a ‘press-stud-like’
structure. The meshwork might therefore be generated because
lamin filaments polymerise between adjacent NPCs, and
proteins within the press stud act analogously to cytoplasmic
IFAPs to control the 2D organisation of the network. There is
now considerable evidence, both from in vitro studies and from
mutant strains of Drosophila that do not express house-keeping
lamins, for a structural relationship between lamina assembly
and NPC assembly and stability (Smythe et al., 2000; Lenz-
Böhme et al., 1997). There is no data to suggest how the press
stud is formed and what proteins reside within the structure.
How do A-type lamins fit into this model? Several lines of
evidence suggest that A-type lamins are organised into the
lamina in a way that is distinct from that in which B-type
lamins are organised. Since A-type lamins are not expressed in
embryonic cells (Stick and Hausen, 1985; Lehner et al., 1987;
Rober et al., 1989) and are dispensable for development
(Sullivan et al., 1999), they are clearly not required for
assembly of the basic lamina. Moreover, although lamin A is
readily incorporated into the lamina of in vitro assembled
sperm pro-nuclei, this occurs through the formation of hetero-
oligomeric associations with lamin B3, and, in the absence of
lamin B3, lamin A forms small aggregates in the nucleoplasm
(Dyer et al., 1999). During NE reassembly after mitosis in
somatic cells, B-type lamins appear at the nuclear periphery
early in telophase, whereas A-type lamins first appear in the
nucleoplasm and arrive at the NE only during G1 phase
(Bridger et al., 1993; Broers et al., 1999; Dechat et al., 2000).
A significant proportion of A-type lamins is readily extracted
from the lamina of a range of cell lines, whereas B-type lamins
are completely insoluble. This finding is consistent with the
fact that several dominant negative A-type and B-type lamin
mutants that form nucleoplasmic aggregates cause the
relocation of A-type lamins from the NE to the aggregates but
do not affect the distribution of B-type lamins (Vaughan et al.,
2000; Izumi et al., 2000). These reports highlight two
properties of lamina filaments: (1) the basic structure is highly
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Fig. 3. Field emission in-lens scanning
electron micrograph showing the lamina of
a manually isolated oocyte germinal vesicle
envelope from the amphibian Xenopus
laevis. The lamina appears as asquare lattice
flattened to the membrane and interacting
with the nuclear pore ring. Arrows illustrate
‘press-stud-like’ structures positioned where
lamin filaments cross. NPC=nuclear pore
complexes. Picture courtesy of Martin W.
Goldberg, Patterson Institute for Cancer
Research.
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insoluble; and (2) the stability of this
structure is based around strong molecular
interactions presumably between adjacent
B-type lamin dimers and between B-type
lamin dimers and their INM-protein
binding partners. A-type lamins appear to
be incorporated into the lamina through
hetero-oligomeric associations with B-type
lamins, although this association may well
be stabilised by additional interactions
between A-type lamins and the INM
proteins LAP1C and emerin. 
We propose the following model to
explain the association of lamin A with the
lamina. Lamin A dimers form tetramers
within the nucleoplasm through half-
staggered anti-parallel associations. The
tetramers then associate with lamin B
dimers through head-to-tail and anti-
parallel associations at the NE. If
associations between A-type and B-type
lamins occur at the NE, there may be a
ligand that recruits lamin A tetramers to
the NE. For pre-lamin A, the ligand is
probably an isoprene receptor. However,
for mature lamin A, the ligand must be
another protein, and obvious candidates
are emerin and LAP1C. Thus, we envisage
that emerin recruits mature lamin A to a
position where it can integrate into the
lamina filament (Fig. 4). LAP1C might
further stabilise the association of lamin A
with the NE, since the amount of LAP1C
in the NE is proportional to the amount of
lamin A and/or C (Powell and Burke,
1990). 
How does lamin C fit with this model?
Several lines of investigation now suggest
that lamin C associates with the lamina by
interacting with lamin A. In several cancer
cell lines in which lamin A is not
expressed, lamin C is located in the
nucleolus rather than at the NE (Vaughan
et al., 2000; Venables et al., 2000). Moreover, when
fluorescently labelled lamin C is injected into the nuclei of
Swiss 3T3 cells, it forms aggregates in the nucleoplasm that
persist for several hours. In contrast, when the same
fluorescently labelled lamin C is co-injected into Swiss 3T3
cells with lamin A, it is incorporated into the NE rapidly (Pugh
et al., 1997). The fact that lamin C expressed transiently in
murine embryonal carcinoma cells that are arrested in S phase
accumulates in the nucleoplasm is consistent with these data
(Horton et al., 1992). Finally, in Sw13 cells that express very
low levels of lamin A, lamin C is located in the nucleolus.
When GFP–lamin-A is overexpressed in these cells,
endogenous lamin C relocates to the NE (Vaughan et al., 2000).
If lamin C localisation at the NE depends on lamin A, then the
model is modified as follows: lamin A and lamin C form anti-
parallel tetramers in the nucleoplasm. These tetramers are then
incorporated into the lamina through the formation of head-to-
tail associations with lamin B oligomers at the NE (Fig. 4).
A number of points about this model should be made
explicit. The amounts of both LAP1C and emerin at the INM
are probably proportional to the amount of lamin A and lamin
C (Powell and Burke, 1990; Sullivan et al., 1999; Vaughan et
al., 2000). Therefore, how can A-type lamins be recruited to
the NE by either protein, if both proteins are recruited to the
INM by lamins A and C? One possibility is that pre-lamin A
initially recruits a seeding population of emerin and LAP1C to
the INM, and this population then recruits mature lamin A.
Alternatively, since LAP1 proteins and emerin bind to lamin
B1 in vitro, perhaps the assembly of B-type lamins at the INM
during telophase recruits sufficient emerin or LAP1C to initiate
recruitment of lamin A. Differences in the behaviour of A-type
and B-type lamins at telophase support this model.
Recruitment of B-type lamins to the NE at telophase is both
rapid and occurs over the entire surface of chromosomes. In
contrast, recruitment of lamin A and lamin C is much slower
and occurs at focal points in which emerin is also present
emerin LAP2b
LAP1C
Lamin A/C tetramer forms in nucleoplasm
and is recruited to INM via association with
lamin B polymer and emerin
Association of lamin A/C at INM recruits emerin and LAP1C from the ER to form a stable 
complex at the INM
Lamina
Lamina
Lamin A
Lamin C
B-type lamins
Fig. 4. Incorporation and stabilisation of A-type lamins at the INM. A-type lamin tetramers
are incorporated into the INM by head-to-tail and anti-parallel associations with B-type
lamin filaments. Recruitment of these lamins to the INM leads to further recruitment of
emerin and LAP1C from the ONM/ER to the INM, stabilising the A-type lamins. ‘Lamina’
indicates where lamin filaments are assembling.
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(Dabauville et al., 1999). These dynamics fit the constraints of
the model, since the model predicts that emerin and lamin A
limit the rate of each other’s incorporation at the INM. 
Internal lamins
The concept of internal lamin structures was first proposed
some years ago (Goldman et al., 1992; Bridger et al., 1993).
Since that time a number of investigations have supported the
notion that A-type lamins not only associate with the NE but
also form some sort of internal nucleoskeleton (Hozak et al.,
1995). Two distinct types of structure appear to exist. First,
tubular invaginations of the NE project into the nucleus, often
making contact with the nucleolus; these structures are
dynamic and continually reorganise (Fricker et al., 1997;
Broers et al., 1999). Second, A-type lamins and specifically
lamin A have been reported to be components of an internal
nucleoskeleton (Hozak et al., 1995) and are associated with
nuclear bodies such as nuclear speckles (Jagatheesan et al.,
1999). FRAP studies in CHO cells that stably express
GFP–lamin-A also reveal the presence of an internal lamin A
population that has distinct solubility properties compared with
the population of lamin A present at the NE (Broers et al.,
1999). Moreover, lamin A and lamin C associate specifically
with chromatin-binding proteins such as LAP2 a and p110RB
in vitro and appear to influence the cellular distributions of
each protein (Ozaki et al., 1994; Dechat et al., 2000;
Markiewicz et al., 2000; unpublished data). Thus, internal
populations of lamin A and lamin C might anchor or organise
components of a nuclear matrix. 
Dominant mutations in A-type lamins and their
relationship to nuclear structure
Recent reports have identified several mutations in the gene
encoding lamin A and lamin C that give rise to a variety of
dominant congenital diseases. These include Emery-Dreifuss
muscular dystrophy (Bonne et al., 1999; Raffaele di Barletta et
al., 2000), a dilated cardiomyopathy (Fatkin et al., 1999) and
most recently a congenital lipodystrophy (Cao and Hegele,
2000; Shackleton et al., 2000). Mutations giving rise to the
cardiomyopathy occur mainly within the rod domain and affect
coil 1a and coil 1b, although a single missense mutation is
located at the C terminus (Brodsky et al., 2000; Fatkin et al.,
1999). One mutation giving rise to EDMD leads to insertion
of a stop codon after residue six and is effectively null. More
commonly, EDMD is caused by missense mutations in two
separate clusters of highly conserved residues within regions
of the tail domain common to lamin A and lamin C or
throughout the rod domain (Bonne et al., 1999; Raffaele di
Barletta et al., 2000). Most interestingly, the mutations that
cause the lipodystrophy are missense mutations but on this
occasion in residues lying between the two EDMD clusters
(Cao and Hegele, 2000) (Fig. 5). 
Why do these mutations give rise to such a diverse group of
diseases, and why do mutations within essentially the same
general region of the lamin A and lamin C tail cause two
distinct phenotypes? At a molecular level, a number of simple
explanations might be put forward. 
Lamin-A/C–emerin interactions
EDMD occurs in two distinct forms: an autosomal dominant
form caused by mutations in the lamin A/C gene (Bonne et al.,
1999; Raffaele di Barletta et al., 2000), and an X-linked form
caused by mutations in emerin (Maninal et al., 1996). Several
lines of evidence suggest that emerin binds to lamins in vitro
(Fairley et al., 1999; Clements et al., 2000). In addition, emerin
co-localises with A-type lamins but not B-type lamins during
NE reassembly (Dabauvalle et al., 1999). Our own data as well
as evidence from the lamin-A- and lamin-C-knockout mouse
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Fig. 5. Distribution of lamin A and lamin C mutations causing dilated cardiomyopathy with conduction block disease, EDMD and Dunnigen-
type partial lipodystrophy in relation to known lamin interaction domains. In the diagram these domains include the LAP2a -binding domain,
emerin-binding domain, lamin B-binding domain, chromatin-binding domain and chromosome-binding domain. The positions of the various
binding domains are indicated by coloured bars above or below the cartoon as follows: red bar=a site of lamin-B–lamin-A/C interaction; purple
bar=chromosome-binding domain; green bar=LAP2 a -binding domain; yellow bar=emerin-binding domain; blue bar=chromatin-binding
domain.
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suggest that emerin is anchored at the INM through a specific
association with lamin A (Vaughan et al., 2000; Sullivan et al.,
1999). In yeast two-hybrid screens, the site of emerin-lamin
interactions has been mapped to the tail domain. Moreover, in
competition reactions, emerin interacts preferentially with
lamin C. Thus we anticipate that emerin-lamin interactions are
mediated by residues in the lamin A and lamin C tail that are
mutated in EDMD. 
Lamin-A/C–lamin-B interactions
B-type lamins are also lamin-A-binding proteins. In extracts of
Xenopus eggs, human lamin A forms stable oligomeric
associations with lamin B3, which appear to mediate the
association of lamin A with the lamina in sperm pronuclei
(Dyer et al., 1999). In addition, dominant negative mutants of
lamin B1 recruit lamin A and lamin C but not lamin B1 or
lamin B2 from the nuclear envelope to nucleoplasmic
aggregates, when expressed in a range of tissue culture cell
lines (Izumi et al., 2000; Vaughan et al., 2000). These dominant
negative mutants are created by deletion of the CaaX motif.
Further deletion of the first 33 residues of the N terminus and
of the C terminus up to the NLS does not affect the ability of
the mutant protein to form nucleoplasmic aggregates or to
recruit lamin A and lamin C to those aggregates. Mutant
proteins in which coil 1a and part of coil 1b (including the helix
initiation sequence) are deleted also form nuclear aggregates.
However, lamin A and lamin C are not recruited to these
aggregates, which suggests that coil 1a and coil 1b of lamin B1
are essential for lamin A and lamin C associations (Izumi et
al., 2000). If lamin A and lamin C and lamin B1 tetramers
form, as predicted, through anti-parallel associations (Quinlan
et al., 1995), the lamin A and lamin C residues that are mutated
in congenital cardiomyopathies fall within a region that would
be required for the formation of tetramers with lamin B1 (Fig.
5). Finally, mutations in the rod domain that cause EDMD
might influence anti-parallel associations either between A-
type lamins and B-type lamins or between lamin A and lamin
C, or might prevent helix initiation and thus destabilise dimers.
Lamin-A/C–LAP2a interactions
How might one explain the fact that mutations lying between
the EDMD clusters in the lamin A and lamin C tail cause
lipodystrophy? Is there another lamin-A- and lamin-C-binding
partner that associates with this region of each protein? We
have recently shown that the non-nuclear-membrane LAP
family member LAP2a specifically associates with lamin A
and lamin C in vivo and in vitro. The region within the lamin
A and lamin C tail that binds to LAP2 a spans that containing
the lipodystrophy mutations (and indeed the EDMD
mutations). Therefore, is LAP2a involved in EDMD or
lipodystrophy or both? As yet there is no direct evidence for
Fig. 6. Electron micrograph illustrating
fragile NEs in skeletal muscle from a patient
suffering from X-EDMD. NE=nuclear
envelope; Chr=chromatin; the arrow shows
areas in which the NE is disrupted;
arrowhead shows areas in which chromatin
is extruded into the cytoplasm. Bar, 200 nm.
Micrograph courtesy of Prof. I.
Hausmanowa-Petriciewicz and Prof. A.
Fidzianska, Warsaw, Poland.
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any of these possibilities; however, consider one factor: LAP2 a
is a chromatin-associated protein that forms part of the
structure referred to as the nuclear matrix. As such, this protein
does not associate with the NE and indeed does not co-localise
with NE lamins (Dechat et al., 1998; Dechat et al., 2000).
However, A-type lamins within the nucleoplasm do co-localise
with LAP2a and, importantly, LAP2 a distribution is
influenced by the distribution of A-type lamins in vivo (Dechat
et al., 2000). Therefore, we can assume that LAP2 a and emerin
associate with completely different subpopulations of A-type
lamins, even though they might associate through similar
regions of the tail domain. Whether mutations in NE-
associated lamins are involved mainly in EDMD, whereas
mutations in nucleoplasmic lamins are involved in
lipodystrophies, remains to be seen. Remember, in the lamin-
A- and lamin-C-knockout mouse, complete absence of lamin
expression leads to EDMD-like phenotypes and an absence of
white fat. Clearly, under these circumstances, neither NE-
associated lamins nor nucleoplasmic lamins are present.
Nuclear defects associated with EDMD 
A number of nuclear architectural defects associated with
EDMD have now been described. These are mainly associated
with the X-linked form of the disease and include aberrant
distribution of heterochromatin, fragility within the NE and
leakage of lamins into the cytoplasm (Fidzianska et al., 1998).
In the lamin-A- and lamin-C-knockout mouse, similar nuclear
defects are also observed (Sullivan et al., 1999). These defects
appear to be similar to those evident in IF-fragility syndromes.
Most IF diseases result in tissue or cell fragility. For example,
skin-blistering disorders arise through mutations in several
keratins (Chan et al., 1993; Chipev et al., 1994; Rugg et al.,
1993) or plectins. These mutations compromise the IF
cytoskeleton, weakening associations with desmosomes or
bundling of filaments. At the cellular level the result is fragile
associations between cells such that fractures occur between
specific epithelial layers within the skin and at sites that are
vulnerable to wear and tear (Irvine and McLean 1999).
Preliminary immnuofluorescence investigations of lamin and
emerin organisation in EDMD tissues have been carried out,
but no gross differences in organisation of either protein was
reported (Bonne et al., 1999). There has as yet been no
thorough ultrastructural examination of lamina filament
organisation in EDMD tissues. Indeed, lamina filament
organisation in nuclei other than large amphibian germinal
vesicles has been achieved only in one study, which depended
upon FESEM microscopy (Zhang et al., 1986). Therefore, it is
unclear whether or not filament organisation is compromised
in affected tissues. However, fragility of the NE is an obvious
feature of absence either of emerin or of lamin A and lamin C
(Fidzianska et al., 1998; Sullivan et al., 1999 – see Fig. 6). If
we consider this disease, and indeed the cardiomyopathy, to be
an IF-fragility syndrome, then we can propose the following
model to explain the disease at both a molecular and a cellular
level.
Lamin A and lamin C are incorporated into the lamina
through a minimum of two molecular interactions. The basic
and necessary interaction is through anti-parallel associations
between A-type lamin dimers and B-type lamin dimers (Fig.
4). The B-type lamin dimers form stable associations with the
INM (as explained above), but in this configuration A-type
lamins are not stably associated with the INM. Therefore a
second stabilising interaction occurs through associations
between the lamin A and lamin C tail, and emerin. Other
associations, such as interactions between A-type lamins and
LAP1C (Powers and Burke, 1990), might make the association
of this lamin with the NE even more stable. If this model is
correct, one should be able to predict the results of a number
of experiments. For example, in FRAP studies involving GFP-
lamin-A, the recovery time for bleached regions of NEs is 2-4
hours (Broers et al., 1999). If emerin stabilises the association
of lamin A with the NE, then mutations in emerin or an absence
of emerin should increase the rate of dissociation and re-
association of lamin A with the lamina and therefore decrease
the recovery time after photobleaching. The same outcome
should be true of the reverse experiment. Emerin localisation
at the INM is dependent upon its interaction with lamin A
(Vaughan et al., 2000). Therefore EDMD mutations in the
lamin A/C tail (but not mutations associated with dilated
cardiomyopathy or partial lipodystrophy) ought to lead to
increased mobility of emerin and again an increase in the rate
of recovery after photobleaching. With respect to dilated
cardiomypathy, the model suggests that association of lamin A
and lamin C with lamin B is principally through anti-parallel
associations. This could be tested in assays that measure
protein-protein interactions in vitro, such as BIACORE or the
yeast-two hybrid system (Clements et al., 2000; Vaughan et al.,
2000). Moreover, one might also predict that identical
mutations in the rod domain of lamin B1 or B2 affect the
stability of lamin A within the lamina, and again this could be
investigated by FRAP. Alternatively, some EDMD mutations
within the rod domain might disrupt the helix, and one would
predict that such mutations give rise to unstable proteins.
Finally, mutations that affect lamin-A/C–LAP1C interactions
might also result in a muscular dystrophy or a cardiomyopathy.
The cellular question is clearly this: if lamin A and lamin C
are ubiquitously expressed, why do mutations in these proteins
principally affect cardiac and skeletal muscle? At one level this
question might be fairly simple to address. Both the dilated
cardiomyopathy and EDMD are notable for very variable
penetrance (Brodsky et al., 2000). In EDMD, skeletal muscle
wastage progresses very slowly, and patients are mainly at
risk of sudden heart failure (Emery, 1989). Therefore, the
differences between EDMD and dilated cardiomyopathy are
more apparent than real. Both diseases can emerge over some
thirty to forty years. Presumably, the NE is vulnerable to
damage in contractile tissues such as skeletal and cardiac
muscle. This vulnerability may be increased because, in
muscle, B-type lamins are apparently expressed at reduced
levels (Manilal et al., 1999). If the absence of emerin from the
NE or mutations in lamins A and C destabilises the association
of these lamins with the NE, the lamina as a whole would
become less effective as a load-bearing structure, particularly
in muscle. Eventually, this general fragility translates into
physical damage leading to cell death and tissue damage.
Physical damage manifests itself as fractures at the NE and
the leakage of lamins and chromatin into the cytoplasm
(Fidzianska et al., 1998 and Fig. 6). In skeletal muscle, the
damage might be limited because muscle fibres are a
syncitium, and not all nuclei will be damaged within a single
muscle fibre. If sufficient numbers of nuclei become damaged,
and the fibre is compromised, individual muscle fibres can be
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replaced. In contrast, in cardiac muscle, loss of individual
cardiomyocytes in adults will be cumulative and will
eventually lead to conduction blocks. Therefore, we propose
that the aetiology of both diseases can be explained by an
accumulation of damaged nuclei as a result of a reduction in
the load-bearing properties of the lamina. Note that a novel A-
kinase-associated protein termed mAKAP is expressed
exclusively in skeletal and cardiac muscle, localises to the INM
and maps to a region of chromosome 14 that is linked to
Arrythmogenic right ventricular dysplasia (ARVD) (Kapiloff
et al., 1999). The presence of mAKAP at the INM of these
tissues localises PKA to the lamina. Perhaps the function of
PKA at this site is to detect and respond to damaged lamina
filaments.
Although fragility may explain the cellular pathology
associated with EDMD and cardiomyopathy it is more difficult
to use this model to explain the lipodystrophy. An alternative
hypothesis is that this disease (and possibly the other diseases)
are promoted because lamin complexes (either lamin A/C and
emerin or lamin A/C and LAP2a ) are involved in tissue-
specific gene regulation. Some evidence for this hypothesis has
been reported in that lamins bind to the transcriptional
regulators p110RB (Ozaki et al., 1994) and BAF1 (Furukawa,
1999). Moreover, ectopic expression of lamin A in myoblasts
has been reported to induce the synthesis of muscle-specific
genes (Lourim and Lin, 1990). Therefore an alternative
hypothesis termed the ‘gene expression’ hypothesis has been
proposed recently, and on the basis of this hypothesis one
might assume that the diseases arise through altered gene
expression in either cardiac muscle, skeletal muscle or in
adipocytes. Since both skeletal and cardiac muscle develop
normally in the lamin-A- and lamin-C-knockout mouse
(Sullivan et al., 1999), and penetrance in the diseases is very
variable, one would expect any change in gene expression
resulting from mutations in lamin A/C or emerin to be subtle.
Detecting and cataloguing of these changes is likely to require
DNA chip technology (Cohen et al., 2001).
Conclusions
Mutations in A-type lamins and their associated proteins are
likely to give rise to an increasing range of inheritable diseases.
An understanding of the aetiology of each disease will arise
from an understanding of lamina structure and function. The
models proposed here relate mainly to the likely organisation
of A-type lamins at the INM and how this organisation
influences some INM proteins. In the future, similar models for
the organisation of internal lamin structures will become
necessary if we are to achieve a complete understanding of
molecular mechanisms underlying the various lamin-related
diseases.
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